Immunomodulatory Microbial Metabolites As Potential Predictors of Stem-cell Transplantation Outcomes
Overview
Overview
Affiliations
Affiliations
Soon will be listed here.
References
1.
Swimm A, Giver C, DeFilipp Z, Rangaraju S, Sharma A, Ulezko Antonova A
. Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease. Blood. 2018; 132(23):2506-2519.
PMC: 6284212.
DOI: 10.1182/blood-2018-03-838193.
View
2.
Argelaguet R, Velten B, Arnol D, Dietrich S, Zenz T, Marioni J
. Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets. Mol Syst Biol. 2018; 14(6):e8124.
PMC: 6010767.
DOI: 10.15252/msb.20178124.
View
3.
Fischer J, Bscheider M, Eisenkolb G, Lin C, Wintges A, Otten V
. RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury. Sci Transl Med. 2017; 9(386).
PMC: 5604790.
DOI: 10.1126/scitranslmed.aag2513.
View
4.
Michonneau D, Latis E, Curis E, Dubouchet L, Ramamoorthy S, Ingram B
. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat Commun. 2019; 10(1):5695.
PMC: 6910937.
DOI: 10.1038/s41467-019-13498-3.
View